(MedPage Today) — The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor agonists for diabetes, despite a lower risk of vision-threatening complications, a large retrospective study…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/116943
Author :
Publish date : 2025-08-11 21:35:00
Copyright for syndicated content belongs to the linked Source.
